Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 27, Issue 2, 2015, Pages 260-267

  Robertson, McKaylee ^a   Laraque, Fabienne ^a   Mavronicolas, Heather ^a   Braunstein, Sarah ^a   Torian, Lucia ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

HIV viral load; HIV viral rebound; HIV viral suppression; Initiation of care; Linkage to care; Retention in care

Indexed keywords

CD4 ANTIGEN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; ETHNICITY; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEN WHO HAVE SEX WITH MEN; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; UNITED STATES; VIRAL PHENOMENA AND FUNCTIONS; VIRAL REBOUND; VIRAL SUPPRESSION; VIRUS LOAD; VIRUS TRANSMISSION; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECTS; HEALTH SURVEY; HIV INFECTIONS; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEW YORK CITY; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84920917428     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2014.959463     Document Type: Article

References (28)

1. Attia, S., Egger, M., Muller, M., Zwahlen, M., & Low, N. (2009). Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS, 23, 1397-1404. doi:10.1097/QAD.0b013e32832b7dca
2. Bunnell, R., Ekwaru, J. P., Solberg, P., Wamai, N., Bikaako-Kajura, W., Were, W., ... Mermin, J. (2006). Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS, 20(1), 85-92. doi:10.1097/01.aids.0000196566.40702.28
3. Buskin, S. E., Barash, E. A., Bauer, A. L., Kent, J. B., Garcia-Smith, H. R., & Wood, R. W. (2011). HIV infected individuals presumed to not be receiving HIV medical care: A surveillance program evaluation for investigations and referrals in Seattle, WA. Journal of HIV/AIDS Surveillance & Epidemiology, 3(1), 3.
4. Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., ... Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365, 493-505. doi:10.1056/NEJMoa1105243
5. Das, M., Chu, P. L., Santos, G.-M., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010). Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One, 5(6), e11068. doi:10.1371/journal.pone.0011068.t001
6. Department of Health and Human Services. (2005). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved January 2, 2013, from http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL04072005001.pdf
7. Department of Health and Human Services. (2012). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved September 10, 2012, from http://aidsinfo.nih.gov/guidelines
8. Dombrowski, J. C., Kent, J. B., Buskin, S. E., Stekler, J. D., & Golden, M. R. (2012). Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS, 26(1), 77-86. doi:10.1097/QAD.0b013e32834dcee9
9. Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., ... Partners in Prevention HSV/HIV Transmission Study Team. (2010). Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. The Lancet, 375, 2092-2098. doi:10.1016/S0140-6736(10)60705-2
10. Gill, V. S., Lima, V. D., Zhang, W., Wynhoven, B., Yip, B., Hogg, R. S., ... Harrigan, P. R. (2010). Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. Clinical Infectious Diseases, 50(1), 98-105. doi:10.1086/648729
11. Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. The Lancet, 373 (9657), 48-57. doi:10.1016/S0140-6736(08)61697-9
12. Gray, R. H., Wawer, M. J., Brookmeyer, R., Sewankambo, N. K., Serwadda, D., Wabwire-Mangen, F., ... Rakai Project, T. (2001). Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. The Lancet, 357, 1149-1153. doi:10.1016/S0140-6736(00)04331-2
13. Greenland, S. (1989). Modeling and variable selection in epidemiologic analysis. American Journal of Public Health, 79, 340-349. doi:10.2105/AJPH.79.3.340
14. Le Moing, V., Chêne, G., Carrieri, M. P., Alioum, A., Brun-Vézinet, F., Piroth, L., ... Leport, C. (2002). Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS, 16(1), 21-29. doi:10.1097/00002030-200201040-00004
15. Montaner, J. S. G., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., ... Kendall, P. (2010). Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. The Lancet, 376, 532-539.doi:10.1016/S0140-6736(10)60936-1
16. Mugavero, M. J., Amico, K. R., Westfall, A. O., Crane, H. M., Zinski, A., Willig, J. H., ... Saag, M. S. (2012). Early retention in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention. Journal of Acquired Immune Deficiency Syndromes, 59 (1), 86-93. doi:10.1097/QAI.0b013e318236f7d2
17. New York City Department of Health and Mental Hygiene. (2011). Recommendation to expand antiretroviral therapy to all persons living with HIV: Frequently asked questions for healthcare providers December 1, 2011. Retrieved November 15, 2012, from http://www.nyc.gov/html/doh/downloads/pdf/ah/nyc-hivart-faq-provider.pdf
18. Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., ... Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. The New England Journal of Medicine, 342, 921-929. doi:10.1056/NEJM200003303421303
19. Russell, S. (2010, April 4). City endorses new policy for treatment of H.I.V. New York Times, p. A25a.
20. State of New York. Public Health Law Article 21 (1983).
21. Public Health Law Article 27-F - HIV and AIDS Information;
22. Public Health Law Article 21, Title III - HIV Reporting and Partner Notification (1998);
23. Code of Administrative Rules and Regulations, Title 10 Part 63 (2000).
24. The White House. (2010). National HIV/AIDS Strategy for the United States. Washington, DC: Office of National AIDS Policy.
25. Torian, L. V., & Wiewel, E. W. (2011). Continuity of HIV-related medical care, New York City, 2005-2009: Do patients who initiate care stay in care? AIDS Patient Care and STDs, 25(2), 79-88. doi:10.1089/apc.2010.0151
26. Torian, L. V., & Xia, Q. (2013). Achievement and maintenance of viral suppression in persons newly diagnosed with HIV, New York City, 2006-2009: Using population surveillance data to measure the treatment part of "test and treat". Journal of Acquired Immune Deficiency Syndromes, 63, 379-386. doi:10.1097/QAI.0b013e3182926b02
27. Udeagu, C. C., Webster, T. R., Bocour, A., Michel, P., & Shepard, C. W. (2013). Lost - or just not following up? Public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS (London, England), 27, 2271-2279. doi:10.1097/QAD.0b013e328362fdde
28. Wegzyn, C. M., & Wyles, D. L. (2012). Antiviral drug advances in the treatment of human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV). Current Opinion in Pharmacology, 12, 556-561. doi:10.1016/j.coph.2012.06.005